Christoph Huber founded BioNTech SE and Ganymed Pharmaceuticals AG. Currently, Dr. Huber holds the position of Chairman for Association For Cancer Immunotherapy. Dr. Huber is also on the board of AFFiRiS AG, BioNTech SE and Ci3 Management UG.

He previously held the position of Chairman-Hematology & Oncology Department at The Johannes Gutenberg University of Mainz and Vice Chairman-Supervisory Board at Ganymed Pharmaceuticals AG.

Christoph Huber received a doctorate from the University of Innsbruck.